Lutetium Chloride Lu-177

CHEMBL5315062 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
283.3 g/mol
LogP
Phase
4

A radioactive lutetium-177 compound used as a starting material for making targeted radiotherapy agents such as lutetium-177 DOTATATE. When attached to tumor-targeting molecules, lutetium-177 delivers localized radiation to cancer cells.

น้ำหนักโมเลกุล

283.3000 g/mol

TPSA

0.00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

[Cl-].[Cl-].[Cl-].[177Lu+3]

InChI

InChI=1S/3ClH.Lu/h3*1H;/q;;;+3/p-3/i;;;1+2

Molecular Formula

Cl3Lu

HBD / HBA

- / 3

พันธะที่หมุนได้

0

อะตอมหนัก

4

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

A radioactive lutetium-177 compound used as a starting material for making targeted radiotherapy agents such as lutetium-177 DOTATATE. When attached to tumor-targeting molecules, lutetium-177 delivers localized radiation to cancer cells.

Yes, Lutetium Chloride Lu-177 is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL5315062. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 71587001. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.